Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer.

Jennifer R DiamondCarlos BecerraDonald RichardsAlain MitaCynthia OsborneJoyce O'ShaughnessyChun ZhangRandall HennerAnn M KapounLu XuBob StaggShailaja UttamsinghRainer K BrachmannAzeez FarookiMonica Mita

Published in: Breast cancer research and treatment (2020)

ClinicalTrials.gov registration: NCT01973309.

Keyphrases

locally advanced
squamous cell carcinoma
clinical trial
rectal cancer
neoadjuvant chemotherapy
small cell lung cancer
phase ii study
radiation therapy
phase ii
study protocol
open label
double blind
phase iii
randomized controlled trial
chemotherapy induced